MedCity News
NOVEMBER 3, 2024
During HLTH, I spoke with some investors and digital health executives about the types of startups that they haven’t encountered yet — but would like to. The post 3 Types of Startups that Healthcare Leaders Want to See More Of appeared first on MedCity News.
pharmaphorum
NOVEMBER 3, 2024
ESSENCE trial of Novo Nordisk's GLP-1 drug semaglutide shows efficacy in MASH, setting up filings in the US and Europe next year
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
NOVEMBER 3, 2024
While VBC opens the door to new care models, they alone cannot solve another key driver of healthcare costs: many people are diagnosed late in their disease progression when care costs are higher. The post Earlier Detection and Treatment are Essential for Meeting VBC Goals appeared first on MedCity News.
PharmaTech
NOVEMBER 3, 2024
Cell-based assays (CBAs) are key tools for evaluating the potency of new biologic drugs. Catalent’s transcription-based bioassay simplifies and empowers the testing of new biologics.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MedCity News
NOVEMBER 3, 2024
In a recent interview, Elizabeth Mitchell, president and CEO of the Purchaser Business Group on Health, discussed employers’ challenges in accessing medical data, emphasizing the need for transparency and potential strategies to enhance their fiduciary responsibilities. The post PBGH CEO: Transparency is “Table Stakes” and an “Expectation” appeared first on MedCity News.
PharmaTech
NOVEMBER 3, 2024
Recent hurricanes in the US close Baxter plant, shining a spotlight on supply chain fragility again.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Pharmacy Times
NOVEMBER 3, 2024
Two clinical trials with MRD monitoring may be practice changing: TRACERx and AEGEAN.
MedCity News
NOVEMBER 3, 2024
As multi-billion investment continues to pour into the R&D of future obesity medications, the need for evidence generation of health benefits beyond short-term weight loss will be critical to the decision-making of healthcare providers and payers. The post Redefining Clinical Development of Obesity Drugs: What Does Success Look Like? appeared first on MedCity News.
Expert insights. Personalized for you.
107 
Let's personalize your content